Laura Jean Brewster
Psychiatric/Mental Health · Niantic, CTNPI 1124463641
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 341 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 29.5% of the total. Among psychiatric/mental health clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Corium, LLC$649
- Axsome Therapeutics, Inc.$424
- Supernus Pharmaceuticals, Inc.$390
- Lundbeck LLC$339
- plus $1K from 8 others
What the payments were for
- Food & beverage$6,56899%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 127 | $1,954 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 82 | $1,714 |
| Corium, LLC | 34 | $649 |
| Axsome Therapeutics, Inc. | 14 | $424 |
| Supernus Pharmaceuticals, Inc. | 16 | $390 |
| Lundbeck LLC | 15 | $339 |
| Otsuka America Pharmaceutical, Inc. | 10 | $246 |
| Alkermes, Inc. | 9 | $215 |
| Collegium Pharmaceutical, Inc. | 9 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| Ironshore Pharmaceuticals Inc. | 6 | $132 |
| Tris Pharma Inc | 7 | $111 |
| Sunovion Pharmaceuticals Inc. | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$433
- CAPLYTA$229
- QELBREE$150
- ARISTADA INITIO$108
- VRAYLAR$102
How this compares
$6,615 in reported general payments places this provider in the 95th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 35 | $47,831 |
| RexultiBrexpiprazole | 26 | $36,966 |
| Seroquel XrQuetiapine Fumarate | 12 | $15,861 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,629 |
| Asenapine Maleate | 26 | $4,873 |
| Alprazolam ErAlprazolam | 17 | $883 |
| Lorazepam | 14 | $348 |
| Bupropion XlBupropion Hcl | 17 | $292 |
| Metformin Hcl | 13 | $87 |
| Diazepam | 13 | $53 |
| Fluoxetine Hcl | 18 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,954 | $47,83135 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $246 | $36,96626 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $135 | $6,62913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 psychiatric/mental health providers in Connecticut.
Other psychiatric/mental health in Niantic
- Michele LitwinNiantic$4K
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Hui HuNorwich$19K
- Patrick GagnonMilford$15K
- Max Greger-MoserNew Haven$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.